Marvin L White - Net Worth and Insider Trading

Marvin L White Net Worth

The estimated net worth of Marvin L White is at least $447,859 dollars as of 2024-12-28. Marvin L White is the Director of Emergent BioSolutions Inc and owns about 54,092 shares of Emergent BioSolutions Inc (EBS) stock worth over $447,341. Marvin L White is the Director of Washington Prime Group Inc and owns about 556 shares of Washington Prime Group Inc (WPGGQ) stock worth over $456. Marvin L White is also the President and CEO of Aptevo Therapeutics Inc and owns about 13 shares of Aptevo Therapeutics Inc (APVO) stock worth over $63. Details can be seen in Marvin L White's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Marvin L White has not made any transactions after 2024-11-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Marvin L White

To

Marvin L White Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Marvin L White owns 5 companies in total, including Emergent BioSolutions Inc (EBS) , Aptevo Therapeutics Inc (APVO) , and CoLucid Pharmaceuticals Inc (CLCD) among others .

Click here to see the complete history of Marvin L White’s form 4 insider trades.

Insider Ownership Summary of Marvin L White

Ticker Comapny Transaction Date Type of Owner
EBS Emergent BioSolutions Inc 2024-11-11 director
APVO Aptevo Therapeutics Inc 2019-06-14 director & President and CEO
CLCD CoLucid Pharmaceuticals Inc 2017-03-01 director
LIMIT LIMIT 2016-05-17 director
LIMIT LIMIT 2014-05-08 director

Marvin L White Latest Holdings Summary

Marvin L White currently owns a total of 3 stocks. Among these stocks, Marvin L White owns 54,092 shares of Emergent BioSolutions Inc (EBS) as of November 11, 2024, with a value of $447,341 and a weighting of 99.88%. Marvin L White owns 556 shares of Washington Prime Group Inc (WPGGQ) as of June 22, 2015, with a value of $456 and a weighting of 0.1%. Marvin L White also owns 13 shares of Aptevo Therapeutics Inc (APVO) as of June 14, 2019, with a value of $63 and a weighting of 0.01%.

Latest Holdings of Marvin L White

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EBS Emergent BioSolutions Inc 2024-11-11 54,092 8.27 447,341
WPGGQ Washington Prime Group Inc 2015-06-22 556 0.82 456
APVO Aptevo Therapeutics Inc 2019-06-14 13 4.81 63

Holding Weightings of Marvin L White


Marvin L White Form 4 Trading Tracker

According to the SEC Form 4 filings, Marvin L White has made a total of 1 transactions in Emergent BioSolutions Inc (EBS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Emergent BioSolutions Inc is the sale of 14,287 shares on November 11, 2024, which brought Marvin L White around $171,015.

According to the SEC Form 4 filings, Marvin L White has made a total of 0 transactions in Washington Prime Group Inc (WPGGQ) over the past 5 years. The most-recent trade in Washington Prime Group Inc is the acquisition of 556 shares on June 22, 2015, which cost Marvin L White around $71,150.

According to the SEC Form 4 filings, Marvin L White has made a total of 0 transactions in Aptevo Therapeutics Inc (APVO) over the past 5 years. The most-recent trade in Aptevo Therapeutics Inc is the acquisition of 2 shares on June 14, 2019, which cost Marvin L White around $44,000.

Insider Trading History of Marvin L White

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Marvin L White Trading Performance

GuruFocus tracks the stock performance after each of Marvin L White's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Marvin L White is 4.91%. GuruFocus also compares Marvin L White's trading performance to market benchmark return within the same time period. The performance of stocks bought by Marvin L White within 3 months outperforms 1 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Marvin L White's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Marvin L White

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 16.39 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 14.57 LIMIT LIMIT LIMIT LIMIT LIMIT

Marvin L White Ownership Network

Ownership Network List of Marvin L White

No Data

Ownership Network Relation of Marvin L White

Insider Network Chart

Marvin L White Owned Company Details

What does Emergent BioSolutions Inc do?

Who are the key executives at Emergent BioSolutions Inc?

Marvin L White is the director of Emergent BioSolutions Inc. Other key executives at Emergent BioSolutions Inc include SVP & Bioservices William Hartzel , Interim CEO Miller H Haywood Iii , and SVP & Products Business Paul Anthony Williams .

Emergent BioSolutions Inc (EBS) Insider Trades Summary

Over the past 18 months, Marvin L White made 1 insider transaction in Emergent BioSolutions Inc (EBS) with a net sale of 14,287. Other recent insider transactions involving Emergent BioSolutions Inc (EBS) include a net sale of 12,919 shares made by Kathryn C Zoon , a net sale of 25,000 shares made by Donald W Degolyer ,

In summary, during the past 3 months, insiders sold 39,287 shares of Emergent BioSolutions Inc (EBS) in total and bought 0 shares, with a net sale of 39,287 shares. During the past 18 months, 52,206 shares of Emergent BioSolutions Inc (EBS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 52,206 shares.

Emergent BioSolutions Inc (EBS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Emergent BioSolutions Inc Insider Transactions

No Available Data

Marvin L White Mailing Address

Above is the net worth, insider trading, and ownership report for Marvin L White. You might contact Marvin L White via mailing address: 2273 Research Blvd, Suite 400, Rockville Md 20850.

Discussions on Marvin L White

No discussions yet.